Expert Business Consulting for Cancer Treatment and Prevention
CaperRX Inc. is a business consulting firm with a focus on cancer treatment and prevention. Our team of experienced professionals is dedicated to providing tailored solutions to meet the needs of our customers. Our services include the development of proprietary peptides to safely inhibit cancer-causing proteins and products designed to improve the quality of life and survival of cancer patients. Our highly experienced management team is well-versed in global strategic development, clinical development, and oncology. Please don't hesitate to contact us for more information or to discuss how we can help you.
The Numbers Speak Volumes
- Brain cancer therapeutics was estimated to be a $2.14B market in 2020 with an anticipated compound annual growth rate (CAGR) of 8.8% for the years 2021-2028. Furthermore, the global peptide therapeutics market size was valued at $39.3B in 2021 and is expected to expand at a CAGR of 6.4% from 2022 to 2030.
- We are seeking Investment Partner(s) to reach First in Human more quickly/efficiently.
- Early Exit and Timely ROI (Out-license for Research Development or M&A) based on Proof of Concept in Adjuvant Glioblastoma is a Distinct Possibility; Orphan Drug Designation is Likely.
- Expansion into Other Aggressive Cancers of High Unmet Need Would Follow.
